Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) is the big winner today – largely thanks to optimism surrounding the company’s cancer drug candidate, CYC065. The company just …
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) investors have a smile on their faces Monday, after the drug maker announced positive preclinical data for CYC065, the …
Equity analysts are weighing in today on fiber optics component maker Acacia Communications (NASDAQ:ACIA), residential solar firm Sunrun Inc (NASDAQ:RUN), and drug maker Cyclacel …
